Improving metabolic health in sleep apnea patients using CPAP treatment

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on patients diagnosed with obstructive sleep apnea (OSA) who are planned for continuous positive airway pressure (CPAP) treatment. It aims to explore the relationship between CPAP adherence, sleep duration, and glycemic control in individuals with OSA, particularly those with diabetes or prediabetes. The study seeks to develop a personalized treatment model that considers individual comorbidities and sleep patterns to optimize metabolic health outcomes. By addressing key questions about the effectiveness of CPAP in managing glycemic control, the research aims to enhance treatment strategies for this population.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients diagnosed with obstructive sleep apnea
* Planned for CPAP treatment
* 18 years and above

Exclusion Criteria:

* Patient not wanting to participate in study
* Non-Swedish speaking
* Judged by physician as non-fit for study participation

Where it's running

• Uppsala University
  Uppsala, Uppsala County, Sweden Recruiting

Study contacts

• Study coordinator: Jenny Theorell-Haglow, A.Prof, PhD
• Email: jenny.theorell-haglow@medsci.uu.se
• Phone: +46 18 6110242

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• AI-powered sleep staging and sleep apnea screening using multimodal wearable data

  This study tests AI models that use wearable and sensor data to help identify sleep stages and screen for obstructive sleep apnea in adults undergoing standard sleep testing.

  Recruiting Peking University First Hospital · Beijing, Beijing Municipality · NCT07908160

• Sleep apnea biomarkers and CPAP use after diagnosis

  This study tests whether biomarkers from a diagnostic sleep study can predict how well adults with newly diagnosed obstructive sleep apnea will stick to CPAP therapy after about 3 months.

  Recruiting Clinique du Millenaire · Montpellier · NCT07792746

• Jaw advancement with counterclockwise rotation for obstructive sleep apnea

  This trial tests whether jaw advancement surgery with counterclockwise rotation helps people with moderate to severe obstructive sleep apnea who can't tolerate CPAP breathe better and sleep more soundly.

  Recruiting Dalarna County Council, Sweden · Falun, Dalarna County · NCT07446634

• Eloralintide for people with obstructive sleep apnea who are overweight or obese

  This study will test whether the drug eloralintide helps adults with moderate-to-severe obstructive sleep apnea who are overweight or obese, whether they use PAP therapy or not.

  Recruiting at 100 sites Phase 3 Eli Lilly and Company · Cullman, Alabama and 114 other locations · NCT07369011

• Amnioinfusion to Protect Newborns After Meconium in Amniotic Fluid

  This trial tests whether a structured lactated Ringer's amnioinfusion during labor can reduce breathing problems and related complications in babies whose amniotic fluid contains meconium.

  Recruiting Medical College of Wisconsin · Milwaukee, Wisconsin · NCT07274527

• Long-term use of a nasopharyngeal airway for obstructive sleep apnea

  This follow-up lets people who finished the parent trial keep using a nasopharyngeal airway to see how it works over the long term for obstructive sleep apnea.

  Recruiting at 2 sites University of Michigan · Ann Arbor, Michigan and 1 other locations · NCT07191314

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.